Dr. Nadine Georges Rouphael, MD

Dr. Rouphael practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Dr. Rouphael's NPI, 1578748869, was assigned on January 4, 2008. Dr. Rouphael graduated from St Joseph's University Medical School in 2001. Dr. Rouphael's Georgia license number on file is 056635.

Dr. Rouphael's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Dr. Rouphael's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. The medical group on file is Emory Clinic. Dmand AI also links Dr. Rouphael to 1 more clinical lab, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rouphael practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Rouphael's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Rouphael is board certified in infectious disease by the American Board of Internal Medicine. Dr. Rouphael has a license on file in Georgia.

CMS data shows 47 Medicare services from Dr. Rouphael across 2 procedure codes in 2024, for 27 Medicare patients. Medicare paid $5,194 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 27 Medicare patients who saw Dr. Rouphael in 2024. The largest group is 65 to 74, with 12 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 41% are also on Medicaid. Their average risk score is 3.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rouphael's median patient age at 66, with 48% women.

In 2024, Dr. Rouphael wrote 12 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $16,728 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Rouphael for performance year 2024, reported through an alternative payment model (APM). Dr. Rouphael accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 148 papers to Dr. Rouphael, published from 2008 to 2025. 2020 was the busiest year, with 17. The most frequent topics are Antibodies, Viral, COVID-19 and SARS-CoV-2. Dr. Rouphael has published most often in Vaccines (Basel). Dr. Rouphael's most frequent co-authors are Mark J. Mulligan, MD, Evan J. Anderson, MD and Lindsey Robert Baden, MD.

Dmand AI links Dr. Rouphael to 18 clinical trials, 4 of them phase 4 studies. 4 are still active or recruiting. Conditions studied include COVID-19, Influenza, Human and Orthomyxoviridae Infections. Emory University sponsors the most, 12. Open Payments lists research payments to Dr. Rouphael that name 2 trials.

CMS Open Payments shows 57 general payments to Dr. Rouphael from 6 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 50% of the total. Moderna TX, Inc. paid the most, $48,731. It also lists 3 research payments totaling $3,750 from 2022 to 2023, naming 2 clinical trials.

Dr. Rouphael graduated from St Joseph's University Medical School in 2001.

Dr. Rouphael is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.